ID   Reh/EphA3
AC   CVCL_ZV66
SY   Reh/A3
DR   cancercelllines; CVCL_ZV66
DR   Wikidata; Q98128900
RX   PubMed=27922598;
CC   Sequence variation: Gene fusion; HGNC; 3495; ETV6 + HGNC; 10471; RUNX1; Name(s)=ETV6-RUNX1; TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 3387; EPHA3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 8
//
RX   PubMed=27922598; DOI=10.1038/leu.2016.371;
RA   Charmsaz S., Al-Ejeh F., Yeadon T.M., Miller K.J., Smith F.M.,
RA   Stringer B.W., Moore A.S., Lee F.-T., Cooper L.T., Stylianou C.,
RA   Yarranton G.T., Woronicz J., Scott A.M., Lackmann M., Boyd A.W.;
RT   "EphA3 as a target for antibody immunotherapy in acute lymphoblastic
RT   leukemia.";
RL   Leukemia 31:1779-1787(2017).
//